Healthcare stocks dominate the news
|It has been a day of mixed fortunes for healthcare names on both sides of the Atlantic, says Chris Beauchamp, Chief Market Analyst at online trading platform IG.
FTSE 100 rebounds, helped by AstraZeneca
AstraZeneca’s numbers have put the fight back in the FTSE 100 as investors around the world gear up for a busy 48 hours of earnings and central bank news. Index heavyweight AstraZeneca provided plenty of good news for UK investors on an otherwise poor day for healthcare stocks; both Novo Nordisk and United Health have come under pressure after bad news, though the former’s surge in earnings seems to suggest the market may now be too cautious on the outlook.
Oil rises for a second day
Easing fears around a global trade war have helped to push oil prices higher for a second consecutive session. Trump’s promises of sanctions on Russia if no Ukraine deal is forthcoming seem a bit far-fetched given his previous views, but the news has certainly helped beaten-down oil prices to make some reasonable short-term headway.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.